SCYNEXIS Inc (SCYX)
2.76
+0.35
(+14.52%)
USD |
NASDAQ |
May 17, 16:00
2.76
0.00 (0.00%)
After-Hours: 20:00
SCYNEXIS Enterprise Value: 24.41M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 24.41M |
| May 16, 2024 | 10.81M |
| May 15, 2024 | 5.138M |
| May 14, 2024 | -5.818M |
| May 13, 2024 | -3.173M |
| May 10, 2024 | -6.951M |
| May 09, 2024 | -9.218M |
| May 08, 2024 | -10.73M |
| May 07, 2024 | -10.54M |
| May 06, 2024 | -14.88M |
| May 03, 2024 | -13.37M |
| May 02, 2024 | -13.00M |
| May 01, 2024 | -15.26M |
| April 30, 2024 | -16.40M |
| April 29, 2024 | -11.48M |
| April 26, 2024 | -22.06M |
| April 25, 2024 | -24.71M |
| April 24, 2024 | -23.57M |
| April 23, 2024 | -21.69M |
| April 22, 2024 | -25.84M |
| April 19, 2024 | -25.84M |
| April 18, 2024 | -27.16M |
| April 17, 2024 | -26.60M |
| April 16, 2024 | -26.97M |
| April 15, 2024 | -24.71M |
| Date | Value |
|---|---|
| April 12, 2024 | -25.65M |
| April 11, 2024 | -19.80M |
| April 10, 2024 | -20.55M |
| April 09, 2024 | -18.66M |
| April 08, 2024 | -18.66M |
| April 05, 2024 | -15.64M |
| April 04, 2024 | -16.77M |
| April 03, 2024 | -12.24M |
| April 02, 2024 | -25.46M |
| April 01, 2024 | -23.95M |
| March 31, 2024 | -24.71M |
| March 28, 2024 | -6.705M |
| March 27, 2024 | -8.404M |
| March 26, 2024 | -9.726M |
| March 25, 2024 | -8.216M |
| March 22, 2024 | -9.726M |
| March 21, 2024 | -9.348M |
| March 20, 2024 | -8.971M |
| March 19, 2024 | -7.838M |
| March 18, 2024 | -7.838M |
| March 15, 2024 | -7.460M |
| March 14, 2024 | -5.573M |
| March 13, 2024 | -4.440M |
| March 12, 2024 | -1.797M |
| March 11, 2024 | -1.420M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-27.16M
Minimum
Apr 18 2024
127.05M
Maximum
Jan 03 2022
46.50M
Average
47.58M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.411M |
| Revenue (Quarterly) | 1.373M |
| Total Expenses (Quarterly) | 10.88M |
| EPS Diluted (Quarterly) | 0.01 |
| Profit Margin (Quarterly) | 29.93% |
| Earnings Yield | 72.92% |
| Operating Earnings Yield | 54.88% |
| Normalized Earnings Yield | 55.13 |